Book Value per Share: xtlbio.com (XTLB)
XTL Biopharmaceuticals relies on external R&D contractors, which ensures high scalability during the mass production of drugs. The historical book value per share smooths out market noise, and its current status is 0.00. The company's success depends on FDA approval of lupus therapy drugs, which determines the stability of the patient base.
xtlbio.com - analytical breakdowns and key metrics (XTLB)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:XTL Biopharmaceuticals, Ltd. - XTLB
Book value per share determines the portion of net assets attributable to a single security, allowing for an assessment of the business's intrinsic value independent of market speculation. By analyzing the book value per share, an investor can identify the actual asset backing, which for XTL Biopharmaceuticals (XTLB) is currently exposed to risks stemming from geopolitical barriers that are hindering drug certification and impairing a portion of intangible assets.
Competitors of XTL Biopharmaceuticals (XTLB)
ARGX - Net Assets per Single Share|BNTX - Net Assets per Single Share|Abivax Corp (ABVX) - Book Value per Share|ADMA (admabiologics.com) - Net Assets per Single Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|ANAB - Net Asset Value per Share|Astria Pharma (ATXS) - Accounting Value per Share|enGene Corp (ENGN) - Equity per Share|RAPT - Accounting Value per Share|JBIO (Aerovate Therapeutics) - Book Price of a Share|Net Assets per Single Share Aclaris Therapeutics, Inc.|Net Assets per Single Share Kyverna Therapeutics Inc. (KYTX)|Tiziana Life Sciences PLC (TLSA) - Accounting Value per Share|Accounting Value of a Share Cabaletta Bio Inc (CABA)|Book Value per Share Ventyx Biosciences VTYX|Net Assets per Single Share theratech.com THTX|Book Value per Share AVTX (Avalo Therapeutics)|ELDN: Net Assets per Share|Net Assets per Single Share AGEN|CLYM (Climb Bio, Inc) - Net Asset Value per Share|Net Assets per Single Share Zura Bio Limited ZURA|Share Book Value atyrpharma.com|Adagene (ADAG) - Book Value per Share|Accounting Value of a Share ikenaoncology.com (IMA)|Book Value per Share STTK (Shattuck Labs)|Equillium Inc - Book Value per Share|Net Assets per Single Share Connect Pharma (CNTB)|IMUX: Accounting Value of a Share|ATRA (atarabio.com) - Net Assets per Single Share|InflaRx (IFRX) - Accounting Value per Share|XFOR (X4 Pharma) - Book Value per Share|Book Value per Share Adicet|Book Value per Share CELU (Celularity Inc.)|Accounting Value per Share inmunebio.com (INMB)|BRNS: Book Value per Share|KZR - Net Asset Value per Share|SAB Biotherapeutics, Inc - Accounting Value per Share|Akari Therapeutics, Plc (AKTX) - Book Value per Share|ENLV - Accounting Value per Share|Q32 Bio (QTTB) - Book Price of a Share|GOVX: Book Value per Share|Net Assets per Share Edesa Biotech Inc|Book Value per Share IBIO (iBio Corp)|Accounting Value per Share carismatx.com (CARM)|Book Value per Share BOLT (Bolt Biotherapeutics, Inc.)|HCW Biologics, Inc. - Book Value per Share|APVO - Net Assets per Single Share|AIM: Net Assets per Single Share|aditxt.com - Net Assets per Single Share|Net Assets per Share GRI Bio Corporation|Accounting Value per Share XORTX Therapeutics Inc. (XRTX)|Equity per Share reshapelifesciences.com (HIND)|Accounting Value per Share Revelation Biosciences, Inc.|Book Price of a Share INDP (Indaptus Therapeutics Inc)|Net Assets per Single Share Scinai SCNI|Net Assets per Single Share CalciMedica Inc CALI|AFMD - Book Value per Share|ALLK: Net Assets per Single Share|Net Assets per Single Share hookipapharma.com (HOOK)|IGM Biosciences (IGMS) - Share Book Value|ITOS - Book Value per Share|Accounting Value of a Share Ocean Biomedical Corp|Book Value per Share TCBP|Book Value per Share THRD (thirdharmonicbio.com)